MiR-1246 expression was predominantly restricted to CD166+ cells in primary NSCLC tumours, and largely absent in CD166− tumour cells and normal lung epithelial cells (Supplementary Fig. 2a). This evidence concerns the gene ALCAM and non-small cell lung carcinoma.